Life-span-dependent transcriptional dynamics of the human heart.
Hao Jia, Xiao Chen, Yuan Chang, Yifan Wang et al.
Kernaussage
The study identified PRDM16 as a key regulator of cardiac aging, where its decline leads to senescence and aging-like transcriptional programs in cardiomyocytes, and its restoration improves cardiac function and reverses age-associated transcriptional changes.
Abstract
The human heart undergoes continuous transcriptional remodeling from development through aging, yet the cellular and regulatory features governing this process remain incompletely defined. Here, we generated a single-nucleus RNA sequencing atlas of 442,239 nuclei from 54 nonfailing myocardial tissues of 29 individuals spanning development, adulthood, and aging, covering left and right ventricles. Across all major cell types, we uncovered coordinated yet cell type-specific transcriptional trajectories that converge on progressive loss of gene expression homeostasis, stress responses, and inflammatory signaling over the life span. Cardiomyocytes displayed distinct age-associated transcriptional states enriched for senescence- and disease-related signatures. Regulatory network analysis identified PRDM16 as a transcriptional regulator whose activity declined with age in cardiomyocytes. Functional perturbation of PRDM16 in human cardiomyocyte models induced senescence, metabolic dysfunction, and stress responses, whereas its rebalancing in aged mouse hearts improved cardiac function and partially reversed aging-associated transcriptional programs. Last, leveraging life-span-resolved single-nucleus data, we constructed cardiac transcriptomic age prediction models that closely tracked chronological age in nonfailing hearts and revealed deviations consistent with accelerated aging in cardiomyopathies. Together, this study provides a comprehensive single-nucleus resource of the human heart across the life span and delineates cellular and regulatory features associated with cardiac aging.
Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.
Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.
Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.